Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
D

Failure to Obtain and Document Informed Consent for Psychotropic Medications

Wichita, Kansas Survey Completed on 02-25-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The deficiency involves the facility’s failure to inform a cognitively intact resident or her representative about the risks and benefits of multiple psychotropic medications, including an antianxiety, antidepressant, and antipsychotic. The resident’s EMR documented diagnoses of anxiety, depressive disorder, and drug-induced dyskinesia, and her MDS showed a BIMS score of 15, indicating intact cognition. The MDS and Psychotropic Drug Use CAA documented that she received high-risk psychotropic medications, including two antidepressants and an antianxiety medication, with identified risk factors such as falls and injuries related to falls. Her care plan documented use of an antidepressant for depression, an antianxiety medication for anxiety with a directive to educate the resident and family on risks, benefits, and side effects, and an antipsychotic medication. Physician’s orders showed active prescriptions for Lexapro 10 mg daily for depression, haloperidol 1 mg daily for dyskinesia, trazodone 75 mg at bedtime for dyskinesias, and Klonopin 0.5 mg twice daily for anxiety. However, the clinical record lacked evidence of informed consent for any of these medications. During interviews, a licensed nurse stated she was unaware of the policy when a resident received psychotropic medication. An administrative nurse reported that she or another nurse completed psychotropic evaluations and notified families when new psychotropic medications were prescribed, and that a PA typically documented psychiatric medication management, but the PA did not see this resident because she used an outside provider. The administrative nurse further stated that the facility did not obtain a psychotropic consent for this resident because the off-site provider would obtain it, and no psychotropic consent documentation was present in the facility record despite a policy addressing antipsychotic medication use.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙